Ocugen's Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon - MyChesCo
MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …
Timothy Alexander
